Tebra vs McKesson
Side-by-side comparison of AI visibility scores, market position, and capabilities
Practice management platform for 130K independent physicians from Kareo+PatientPop merger; EHR, billing, and patient acquisition marketing for small practices competing with athenahealth.
About
Tebra (formerly Kareo + PatientPop) is a cloud-based practice management and digital health platform for independent healthcare practices — providing practice management software, electronic health records (EHR), billing and revenue cycle management, patient engagement, and healthcare marketing tools specifically designed for small independent physician practices. Formed through the merger of Kareo (practice management/billing) and PatientPop (healthcare marketing/patient acquisition) in 2022, Tebra serves approximately 130,000 healthcare providers at independent practices across primary care, mental health, dermatology, and specialty care.\n\nTebra's platform addresses the full operational needs of a small medical practice: EHR documentation with templates for common visit types, automated patient appointment reminders and forms, insurance eligibility verification and claims submission, payment collection from patients, and online reputation management (Google reviews, healthcare directory listings). The combined Kareo+PatientPop heritage means Tebra uniquely covers both the clinical and administrative workflow alongside the digital marketing capabilities independent practices need to attract new patients.\n\nIn 2025, Tebra competes in the small practice EHR and practice management market against athenahealth, drchrono, Jane App, and Practice Fusion for independent physician practice software. The independent practice market faces significant headwinds from hospital consolidation — independent physician practices have steadily been acquired into health system employment or affiliated networks, shrinking the addressable market. Tebra's 2025 strategy focuses on the growing behavioral health segment (mental health practices are growing and need modern practice management tools), telehealth integration (virtual visit capability within the EHR workflow), and improving revenue cycle management automation to help practices collect more of what they bill.
Largest US pharmaceutical distributor with $308.9B FY2024 revenue; thin-margin distribution triopoly with Cencora and Cardinal Health; US Oncology Network (1,700+ oncologists) is highest-margin segment.
About
McKesson Corporation is the largest pharmaceutical distributor in North America and a leading healthcare services company, founded in 1833 in New York City by John McKesson and Charles Olcott and now headquartered in Irving, Texas, trading on NYSE (MCK). The company reported approximately $308.9 billion in revenues for fiscal year 2024 (ending March 31, 2024) under CEO Brian Tyler, making it one of the highest-revenue companies in the United States—though the vast majority of revenues represent pass-through pharmaceutical product costs distributed to approximately 40,000 pharmacies, health systems, and medical providers across North America. McKesson operates through four segments: U.S. Pharmaceutical (the dominant distribution engine), Prescription Technology Solutions (pharmacy benefits technology including CoverMyMeds e-prior authorization), Medical-Surgical Solutions (physician office and extended care medical supply distribution), and International (primarily Canadian distribution through McKesson Canada).
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.